Category: AI and Tech News
-
How human organs are rewriting the rules of drug development
Dr. Jenna DiRito talks about why human organs may represent the “missing chapter” in our understanding of disease, and how this approach is already changing conversations with investors and regulators.
-
Evogene and Australian Uni partner to tackle chemotherapy resistance in lung cancer
AI-driven collaboration between the Israeli company and Queensland University of Technology targets cellular pathways to overcome treatment hurdles in non-small cell lung cancer.
-
Seamflow secures $4.5m to deploy AI for testing and certification bottlenecks
London-based AI startup raises seed funding to tackle certification delays in medical devices and industrial sectors.
-
RevealDx wins FDA clearance for lung nodule assessment software
New AI software aims to help radiologists assess lung nodule cancer risk and improve early detection.
-
How ambient AI is capturing healthcare’s unheard data
The Sciensus team discusses how ambient AI captures patient sentiment to augment nurses, personalise care, and help keep patients healthier at home.
-
VUGENE partners with Inotiv to power AI-driven drug discovery
Lithuanian bioinformatics firm launches into pharmaceutical services via a strategic CRO collaboration aimed at accelerating multi-omics analysis.
-
HeartBeam’s stock shows strong pulse after FDA clearance
A cable-free, credit-card sized ECG device for at-home heart monitoring receives regulatory approval, paving the way for a 2026 launch.
-
Brainomix’s AI stroke tool doubles life-saving surgery rates in NHS study
The study indicated that Brainomix 360 Stroke led to a 100% increase in endovascular thrombectomy rates and sped up patient transfers across 107 UK hospitals.
-
RapidAI wins FDA nod for five new AI tools
RapidAI bolsters its clinical AI platform with new FDA-cleared modules designed to enhance neurology, vascular, and radiology care.
-
Sorcero raises $42.5 million for AI adoption in life sciences
The company plans to use the new investment to scale its AI platform and expand applications across global pharmaceutical and medical device sectors.
-
Voio emerges from stealth, launches AI for medical scans
The company has $8.6 million in funds, with the Pillar-0, an open-source AI model developed by UC Berkeley and UCSF.
-
Stereotaxis gains FDA nod for next-gen surgical robot
New GenesisX system eliminates key infrastructure barriers, broadening access to robotic electrophysiology procedures.
Latest posts
-
Navigating the Risks and Rewards of Biomarker-Based Surrogates and Accelerated Approval
The risks and rewards of biomarker-based surrogates are crucial for optimizing clinical trial outcomes and guiding effective treatments.
-
ASH25: Gallop’s LYT-200 shows unprecedented survival in AML
The company’s execs talk about the striking efficacy and safety signals seen in Phase I data, the science behind the molecule, and their vision for transforming AML therapy.
-
Promis reports first human evidence of aβ oligomer reduction by pmn310
PMN310 demonstrates dose-dependent reduction of amyloid-beta oligomers in human CSF, marking a key milestone in Alzheimer’s treatment development.
-
Urologic Health secures $11 million for non-invasive bladder monitoring
Urologic Health raises $11million seed funding to advance a catheter-free bladder monitoring platform toward FDA clearance and US market entry.
-
Novo Nordisk’s denecimig cuts bleeding in hemophilia A regardless of inhibitors
Phase III trial shows once‑monthly and once‑weekly denecimig (Mim8) significantly reduces annualized bleeding rate versus standard care, with up to 95% of patients bleed‑free.